+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Cold Agglutinin Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Cold Agglutinin Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

  • Report
  • April 2025
  • 400 Pages
  • Global
From
Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025 - Product Thumbnail Image

Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Vascular Anomalies- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Anomalies- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GABA A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABA A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hunter Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hunter Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Menorrhagia - Pipeline Insight, 2025 - Product Thumbnail Image

Menorrhagia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Contact Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anthrax - Pipeline Insight, 2025 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Cataract- Pipeline Insight, 2025 - Product Thumbnail Image

Cataract- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Bladder Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Brain Hemorrhage - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Fatigue - Pipeline Insight, 2025 - Product Thumbnail Image

Fatigue - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cachexia - Pipeline Insight, 2025 - Product Thumbnail Image

Cachexia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 130 Pages
  • Global
From
Febrile Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Febrile Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Acromegaly- Pipeline Insight, 2025 - Product Thumbnail Image

Acromegaly- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more